LFMD logo

LFMD
LifeMD Inc

3,610
Mkt Cap
$239.87M
Volume
101,466.00
52W High
$15.84
52W Low
$2.56
PE Ratio
-25.15
LFMD Fundamentals
Price
$5.11
Prev Close
$5.00
Open
$5.15
50D MA
$3.77
Beta
1.70
Avg. Volume
1.2M
EPS (Annual)
-$0.2263
P/B
10.07
Rev/Employee
$498,856.55
$123.43
Loading...
Loading...
News
all
press releases
LifeMD's (LFMD) Buy Rating Reiterated at BTIG Research
BTIG Research restated a "buy" rating and issued a $10.00 price objective on shares of LifeMD in a report on Monday...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
LifeMD (LFMD) Projected to Post Quarterly Earnings on Tuesday
LifeMD (NASDAQ:LFMD) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
MarketBeat·6d ago
News Placeholder
Meta, Microsoft to Trim Workforces Amid AI Spending Bloomberg Businessweek Daily 4/23/2026
On today's episode of Bloomberg Businessweek Daily, Carol Massar and Tim Stenovec speak with Bloomberg Tech Co-Host Ed Ludlow about Meta and Microsoft looking to trim their workforces amid heavy AI...
Bloomberg Markets and Finance-YouTube·11d ago
News Placeholder
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
LifeMD (LFMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·13d ago
News Placeholder
JPMorgan Chase & Co. Has $414,000 Stock Holdings in LifeMD, Inc. $LFMD
JPMorgan Chase & Co. cut its stake in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 85.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,941 shares of the company's stock after selling 351,630 shares...
MarketBeat·19d ago
News Placeholder
Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms
HIMS unites telehealth, records and pharmacy fulfillment on one digital platform, adding AI tools, diagnostics and FDA-approved medicines.
Zacks·20d ago
News Placeholder
LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Moderate Buy" by Brokerages
LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has earned an average recommendation of "Moderate Buy" from the nine analysts that are currently covering the stock, MarketBeat reports. One investment...
MarketBeat·23d ago
News Placeholder
LifeMD (NASDAQ:LFMD) Trading Down 4.2% - What's Next?
LifeMD (NASDAQ:LFMD) Shares Down 4.2% - What's Next...
MarketBeat·26d ago
News Placeholder
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan
Novo Nordisk launches the first Wegovy subscription program. Save on injections and pills through Ro, WeightWatchers, LifeMD, and more.read more...
Benzinga·1mo ago
News Placeholder
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?
CAH sees GLP-1 drugs boost revenue growth, but margins lag as strong demand lifts volumes without significantly improving profitability.
Zacks·1mo ago
<
1
2
...
>

Latest LFMD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.